Theralase Technologies (Germany) Performance
| TTX Stock | 0.18 0.01 5.88% |
Theralase Technologies holds a performance score of 11 on a scale of zero to a hundred. The entity has a beta of -0.94, which indicates possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Theralase Technologies are expected to decrease slowly. On the other hand, during market turmoil, Theralase Technologies is expected to outperform it slightly. Use Theralase Technologies jensen alpha, semi variance, price action indicator, as well as the relationship between the maximum drawdown and daily balance of power , to analyze future returns on Theralase Technologies.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Theralase Technologies are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Theralase Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7.9 M | |
| Free Cash Flow | -4.1 M |
Theralase |
Theralase Technologies Relative Risk vs. Return Landscape
If you would invest 10.00 in Theralase Technologies on August 27, 2024 and sell it today you would earn a total of 8.00 from holding Theralase Technologies or generate 80.0% return on investment over 90 days. Theralase Technologies is generating 1.2175% of daily returns and assumes 8.2945% volatility on return distribution over the 90 days horizon. Simply put, 73% of stocks are less volatile than Theralase, and 76% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Theralase Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theralase Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Theralase Technologies, and traders can use it to determine the average amount a Theralase Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1468
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.29 actual daily | 73 73% of assets are less volatile |
Expected Return
| 1.22 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Theralase Technologies is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theralase Technologies by adding it to a well-diversified portfolio.
Theralase Technologies Fundamentals Growth
Theralase Stock prices reflect investors' perceptions of the future prospects and financial health of Theralase Technologies, and Theralase Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Theralase Stock performance.
| Current Valuation | 47.58 M | |||
| Price To Book | 25.99 X | |||
| Price To Sales | 69.51 X | |||
| Revenue | 780.64 K | |||
| EBITDA | (4.13 M) | |||
| Cash Flow From Operations | (4.03 M) | |||
| Total Asset | 5.94 M | |||
About Theralase Technologies Performance
Assessing Theralase Technologies' fundamental ratios provides investors with valuable insights into Theralase Technologies' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Theralase Technologies is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Theralase Technologies performance evaluation
Checking the ongoing alerts about Theralase Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Theralase Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Theralase Technologies is way too risky over 90 days horizon | |
| Theralase Technologies has some characteristics of a very speculative penny stock | |
| Theralase Technologies appears to be risky and price may revert if volatility continues | |
| Theralase Technologies has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 780.64 K. Net Loss for the year was (4.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Theralase Technologies generates negative cash flow from operations |
- Analyzing Theralase Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Theralase Technologies' stock is overvalued or undervalued compared to its peers.
- Examining Theralase Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Theralase Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Theralase Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Theralase Technologies' stock. These opinions can provide insight into Theralase Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.